Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: Tools for allogeneic transplantation

Transplantation

Volumn 91, Issue 8, 2011, Pages 833-840

  Graves, Scott S ^a,b   Stone, Diane M ^a   Loretz, Carol ^a   Peterson, Laura J ^a   Lesnikova, Marina ^a   Hwang, Billanna ^a   Georges, George E ^a,b   Nash, Richard ^a,b   Storb, Rainer ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Blockade; CD28; Costimulatory molecule; CTLA4 Ig; Cytotoxic T lymphocyte; Regulatory T cells

Indexed keywords

CD28 ANTIGEN; CD3 ANTIBODY; HYBRID PROTEIN; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1C6; MONOCLONAL ANTIBODY 5B8; MONOCLONAL ANTIBODY CD28; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOG; EXTRACELLULAR SPACE; HYBRIDOMA; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MOLECULAR CLONING; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; BINDING SITES, ANTIBODY; CELL PROLIFERATION; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HYBRIDOMAS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; ORGAN TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 79954646791     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31820f07ff     Document Type: Article

References (38)

1. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993; 11: 191.
2. Daikh D, Wofsy D, Imboden JB. The CD28-B7 costimulatory pathway and its role in autoimmune disease. J Leukoc Biol 1997; 62: 156.
3. Buch MH, Vital EM, Emery P. Abatacept in the treatment of rheumatoid arthritis. Arthritis Res Ther 2008; 10(suppl 1): S5.
4. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
5. Pearson TC, Alexander DZ, Winn KJ, et al. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701.
6. Kean LS, Adams AB, Strobert E, et al. Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockadebased immunosuppression. Am J Transplant 2007; 7: 320.
7. Storb R, Yu C, Zaucha JM, et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 1999; 94: 2523.
8. Yu XZ, Bidwell SJ, Martin PJ, et al. CD28-specific antibody prevents graft-versus-host disease in mice. J Immunol 2000; 164: 4564.
9. Snanoudj R, de Preneuf H, Creput C, et al. Costimulation blockade and its possible future use in clinical transplantation. Transpl Int 2006; 19: 693.
10. Vincenti F. Costimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol 2008; 121: 299.
11. Rothstein DM, Sayegh MH. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 2003; 196: 85; erratum in Immunol Rev 2004; 197: 243.
12. Storb R, Epstein RB, Graham TC, et al. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 1970; 9: 240.
13. Deeg HJ, Storb R, Weiden PL, et al. Cyclosporin A and methotrexate in canine marrow transplantation: Engraftment, graft-versus-host disease, and induction of tolerance. Transplantation 1982; 34: 30.
14. Storb R, Raff RF, Appelbaum FR, et al. FK506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated DLA-nonidentical donors. Transplantation 1993; 56: 800.
15. Yu C, Seidel K, Nash RA, et al. Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts. Blood 1998; 91: 2581.
16. Storb R, Yu C, Wagner JL, et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997; 89: 3048.
17. Abrams VK, Hwang B, Lesnikova M, et al. A novel monoclonal antibody specific for canine CD25 (P4A10): Selection and evaluation of canine Tregs. Vet Immunol Immunopathol 2010; 135: 257.
18. Baroja ML, Lorre K, Van Vaeck F, et al. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens. Cell Immunol 1989; 120: 205.
19. Oberg HH, Wesch D, Lenke J, et al. An optimized method for the functional analysis of human regulatory T cells. Scand J Immunol 2006; 64: 353.
20. Deeg HJ, Storb R, Raff RF, et al. Marrow grafts between phenotypically DLA-identical and haploidentical unrelated dogs: Additional antigens controlling engraftment are not detected by cell-mediated lympholysis. Transplantation 1982; 33: 17.
21. Bluestone JA, Liu W, Yabu JM, et al. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant 2008; 8: 2086.
22. Kuemmerle-Deschner JB, Benseler S. Abatacept in difficult-to-treat juvenile idiopathic arthritis. Biologics 2008; 2: 865.
23. Abrams JR, Kelley SL, Hayes E, et al. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 2000; 192: 681.
24. KirkAD,TadakiDK,Celniker A, et al. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. Transplantation 2001; 72: 377.
25. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(-)CD4(-) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295.
26. Vanhove B, Laflamme G, Coulon F, et al. Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody. Blood 2003; 102: 564.
27. Shiao SL, McNiff JM, Masunaga T, et al. Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities. Transplantation 2007; 83: 304.
28. Guillonneau C, Seveno C, Dugast AS, et al. Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients. J Immunol 2007; 179: 8164.
29. Graves SS, Stone D, Loretz C, et al. Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig. Transplantation 2009; 88: 317.
30. Podesta EJ, Solano AR, Attar R, et al. Receptor aggregation induced by antilutropin receptor antibody and biological response in rat testis Leydig cells. Proc Natl Acad Sci USA 1983; 80: 3986.
31. Gross JA, Callas E, Allison JP. Identification and distribution of the costimulatory receptor CD28 in the mouse. J Immunol 1992; 149: 380.
32. Haspot F, Villemain F, Leflanne G, et al. Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and selfrestricted responses. Blood. 2002; 99: 2228.
33. Wagner JL, Burnett RC, DeRose SA, et al. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 1996; 62: 876.
34. Wagner JL, Works JD, Storb R. DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing. Tissue Antigens 1998; 52: 397.
35. Taggart RT, Samloff IM. Stable antibody-producing murine hybridomas. Science 1983; 219: 1228.
36. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495.
37. Lee WS, Suzuki Y, Graves SS, et al. Canine bone marrow derived mesenchymal stromal cells suppress allo-reactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation. Biol Blood Marrow Transplant 2010; [Epub ahead of print].
38. Nash RA, Yunusov M, Abrams K, et al. Immunomodulatory effects of mixed hematopoietic chimerism: Immune tolerance in canine model of lung transplantation. Am J Transplant 2009; 9: 1037.